Spranger, Stefani
Massachusetts Institute of Technology,
United States
2025 Rank: 13466
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 391 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 13466 | 15477 |
| Total Cites | 1586 | 1635 |
| H-index | 19 | 20 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 21 | 21 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 557 | 566 |
| Number of Single+First+Last Authored Papers | 37 | 37 |
| Total Cites to Single+First+Last Authored Papers | 807 | 823 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1328 | 1354 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.21 |
| Self-Citation Percentage |
3.00%
|
|
Spranger, Stefani
Massachusetts Institute of Technology,
United States
2024 Rank: 8576
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 272 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 8576 | 9192 |
| Total Cites | 1693 | 1757 |
| H-index | 21 | 22 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 33 | 33 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 714 | 722 |
| Number of Single+First+Last Authored Papers | 35 | 35 |
| Total Cites to Single+First+Last Authored Papers | 884 | 909 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1393 | 1426 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.23 |
| Self-Citation Percentage |
3.64%
|
|
Spranger, Stefani
Massachusetts Institute of Technology,
United States
2023 Rank: 7928
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 282 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 7928 | 8846 |
| Total Cites | 1748 | 1799 |
| H-index | 21 | 21 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 32 | 33 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 814 | 830 |
| Number of Single+First+Last Authored Papers | 29 | 29 |
| Total Cites to Single+First+Last Authored Papers | 979 | 997 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1404 | 1434 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.25 |
| Self-Citation Percentage |
2.83%
|
|
Spranger, Stefani
Massachusetts Institute of Technology,
United States
2022 Rank: 7290
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 273 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 7290 | 8046 |
| Total Cites | 1855 | 1921 |
| H-index | 20 | 21 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 31 | 31 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 930 | 947 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 1036 | 1053 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1425 | 1465 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.31 |
| Self-Citation Percentage |
3.44%
|
|
Spranger, Stefani
Massachusetts Institute of Technology,
United States
2021 Rank: 7402
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 277 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 7402 | 8213 |
| Total Cites | 2815 | 2922 |
| H-index | 24 | 25 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 48 | 49 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 1462 | 1494 |
| Number of Single+First+Last Authored Papers | 26 | 26 |
| Total Cites to Single+First+Last Authored Papers | 1613 | 1645 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2070 | 2121 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.38 |
| Self-Citation Percentage |
3.66%
|
|
Spranger, Stefani
Massachusetts Institute of Technology,
United States
2020 Rank: 9644
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 231 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 9644 | 10183 |
| Total Cites | 1685 | 1770 |
| H-index | 19 | 20 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 38 | 40 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 973 | 1015 |
| Number of Single+First+Last Authored Papers | 21 | 21 |
| Total Cites to Single+First+Last Authored Papers | 1063 | 1108 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1248 | 1281 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.38 |
| Self-Citation Percentage |
4.80%
|
|